Detalhe da pesquisa
1.
Pandemic influenza A (H1N1) 2009 vaccination in children: a UK perspective.
J Paediatr Child Health
; 49(3): E183-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23253033
2.
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
J Infect
; 87(3): 230-241, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331429
3.
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
Arch Dis Child
; 98(9): 686-91, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23853000
4.
Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
Pediatr Infect Dis J
; 30(11): e203-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21673612